PubRank

I Dvorchik

Author PubWeight™ 41.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 1997 2.57
2 Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant 2006 2.48
3 Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 1999 2.22
4 Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998 1.99
5 Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000 1.82
6 Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant 2009 1.59
7 Should hepatomas be treated with hepatic resection or transplantation? Cancer 1999 1.54
8 An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant 2001 1.48
9 Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg 2001 1.44
10 Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 1997 1.36
11 Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997 1.36
12 Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000 1.33
13 De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 2001 1.30
14 Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant 2006 1.26
15 Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg 1999 1.24
16 Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. J Pediatr Surg 1999 1.14
17 Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr 2000 1.04
18 Hepatic hemangioendothelioma: clinical experience and management strategy. J Pediatr Surg 1999 1.03
19 Predicting outcomes after liver transplantation. A connectionist approach. Ann Surg 1994 1.02
20 Human metapneumovirus infections are associated with severe morbidity in hospitalized children of all ages. Epidemiol Infect 2013 0.94
21 Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation 2002 0.91
22 Strategies to expand the donor pool for pancreas transplantation. Transplantation 1999 0.88
23 Causes of death in patients with unresectable hepatocellular carcinoma. Dig Dis Sci 2007 0.88
24 Liver transplantation in the treatment of hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 1998 0.81
25 Hepatobiliary malignancies. Primary hepatic malignant neoplasms. Surg Clin North Am 1999 0.80
26 An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation 1999 0.80
27 Hyperbaric oxygen therapy for hepatic artery thrombosis after liver transplantation in children. Liver Transpl Surg 1999 0.80
28 Undetected hepatocellular carcinoma: clinical features and outcome after liver transplantation. Liver Transpl Surg 1998 0.79
29 Hepatic and intestinal transplantation at the University of Pittsburgh. Clin Transpl 1998 0.78
30 Liver transplantation for acute liver failure: outcome analysis. J Viral Hepat 1997 0.78
31 Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma. Hepatology 1997 0.77
32 Kidney transplantation with bone marrow augmentation: five-year outcomes. Transplant Proc 2001 0.76
33 Chronic allograft nephropathy score before sirolimus rescue predicts allograft function in renal transplant patients. Transplant Proc 2007 0.75
34 Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection. Transplant Proc 2001 0.75
35 A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients. Transplant Proc 2002 0.75
36 Quantitative assessment of the development of hepatoma in a buffalo rat model. Transplant Proc 1997 0.75
37 Should reimbursement be denied for liver transplantation in patients with hepatocellular carcinoma? JAMA 1997 0.75
38 Potential use of marginal donors for pancreas transplantation. Transplant Proc 1999 0.75
39 Effects of cisplatin dose intensity on response and survival for patients with unresectable and untransplantable hepatocellular carcinoma: an analysis of 57 patients. Gan To Kagaku Ryoho 2000 0.75